JPMorgan Chase & Co

JPMorgan Chase’s 2026 SEC filing reveals strong capital, growing telecom and wine‑estate holdings, and AI‑driven strategy amid tighter Basel rules and regulatory scrutiny.

JPMorgan Chase’s latest 424(b)(2) filings reveal a push for capital growth while selling structured notes with higher-than‑average rates and hidden commodity risks, raising concerns about transparency, investor safety, and potential bias in internal…

JPMorgan Chase plans $80 billion in small‑business loans, adding 1,000 new bankers to serve 10 million SMEs and boost local economies under its American Dream Initiative.

JPMorgan Chase sees a game‑changing Pernod Ricard‑Brown‑Forman merger that could dominate U.S. whiskey & tequila, boost margins, and spark regulatory intrigue—discover the strategic upside and risks.

JPMorgan’s latest equity research shifts and $15–$20B debt deal for EA reveal its confidence in tech giants like Snowflake, Salesforce, and CrowdStrike, while highlighting the gaming industry’s consolidation and regulatory impacts. This strategic in…

JPMorgan’s new peer‑focused research highlights tech, retail, and service trends—showing where gains may lie amid regulation and digital disruption.

JPMorgan revises tech and consumer‑goods targets, citing cost pressures and regulation, signaling a shift in valuation norms amid tightening macro‑economics.

JPMorgan’s upcoming special call highlights a potential record‑setting trading run, spotlighting its tech‑driven edge, risk‑management strength and investor‑focused strategy.

JPMorgan updates valuation models amid market volatility, raising a health‑services target, cutting a medical‑device forecast, and moving a satellite‑comms firm to neutral, showing how data‑driven insights guide investors in a dynamic economy.

JPMorgan’s latest mid‑cap reviews reveal modest target hikes, a cautious outlook on a top medical‑device maker, and key take‑aways on regulation, competition, and dividend appeal for investors.